Prof. Mehmet İlhan Şahin is a highly accomplished otolaryngologist with a strong focus on research and academic contributions in the field of Ear, Nose, and Throat (ENT) diseases. He currently serves as a Professor at Erciyes University, Faculty of Medicine, in the Department of Surgical Medical Sciences, a position he has held since 2023.

Dr. Şahin completed his undergraduate medical education at Hacettepe University in Turkey (1997-2003) and specialized in Otorhinolaryngology at Erciyes University (2006-2010). He further honed his research expertise through a significant Postdoctoral fellowship at Harvard University, Medical School, Massachusetts Eye & Ear Infirmary, United States of America, from 2014 to 2017, where he also served as a Research Assistant in the Department of Otolaryngology.

His research interests broadly encompass Medicine, Health Sciences, Fundamental Medical Sciences, Medical Biology, and particularly Otolaryngology. Dr. Şahin's scientific contributions are evidenced by numerous articles in prestigious journals, including those indexed in SCI-Expanded databases such as SCIENCE ADVANCES, HEARING RESEARCH, and EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. Notably, his work includes studies on the impact of inflammation on hearing, such as "Intracochlear Perfusion of Tumor Necrosis Factor-Alpha Induces Sensorineural Hearing Loss and Synaptic Degeneration in Guinea Pigs" and "NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss."

Beyond his extensive publication record, Prof. Şahin has actively participated in international and national scientific conferences, presenting on diverse topics from cochlear implantation to otogenic complications in COVID-19. He has also supervised multiple theses in the field of medicine. His commitment to the medical community is further demonstrated by his role as Head of Department at Erciyes University since 2024 and his involvement with the Kayseri Medical Chamber as Chairman of the Board.

Prof. Şahin's dedication to advancing otolaryngology through research, clinical practice, and leadership makes him a prominent figure in his field.

Dr. Camille Rochmann, Director of Value & Access at Cilcare.

Cilcare is a French-American biopharmaceutical company dedicated to making hearing a priority in global health through the development of innovative therapies, next-generation diagnostics, and AI-driven solutions for hearing disorders.

Dr. Rochmann earned her Doctor of Pharmacy degree and a Specialized Master's degree in Pharmacoeconomics and Market Access from Paris-Saclay University. She has over 10 years of experience in health economics and outcomes research, including a successful career at Sanofi, where she worked on market access and evidence generation strategies for products in immunology and rare diseases.

Today, she brings this expertise to the field of hearing health, where she is leading efforts to ensure that innovation translates into meaningful value for patients, healthcare systems, and society.